Miconazol Slavia (Miconazole Nitrate)

Miconazole nitrate blocks the fungal enzyme lanosterol 14α‑demethylase, which is essential for producing ergosterol, a key component of the fungal cell membrane. Inhibiting ergosterol synthesis disrupts membrane integrity, leading to increased permeability and ultimately fungal cell death, thereby clearing the infection.

The dosage of Miconazol Slavia is determined by the prescribing healthcare professional based on the type and severity of the infection, the patient’s age, and the area of skin to be treated. Patients should follow the prescriber’s instructions regarding the amount to apply and the frequency of application.

Safety data for Miconazol Slavia in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details (including any cold‑chain requirements) and required import documentation.

Miconazol Slavia belongs to the imidazole class of antifungals, which are generally effective against dermatophytes and yeasts. Compared with allylamine agents such as terbinafine, imidazoles have a broader spectrum but may cause more local irritation. Choice of therapy depends on the specific pathogen, infection site, patient tolerance and prescriber preference.

Miconazol Slavia should be stored at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use.

The product is applied topically to the affected skin area. Clean and dry the area before use, then apply a thin layer of the cream or gel as directed by the prescriber, usually twice daily. Wash hands after application unless the hands are the treatment site.

Serious risks, though rare, include severe allergic reactions such as swelling, hives, or difficulty breathing, and extensive contact dermatitis that may lead to secondary bacterial infection. If any of these symptoms occur, discontinue use immediately and seek medical attention.

Individuals with known hypersensitivity to miconazole nitrate or any component of the formulation should not use the product. It should also be avoided on broken, inflamed, or mucous membrane surfaces, and in patients where a systemic antifungal is required without medical supervision.